Abstract
Caspase-3 and -7 represent executioner/effector caspases that directly cause apoptotic morphological changes by cleaving various death substrates. The substrates for caspases generally interact with active caspases, but not with inactive zymogens of caspase or procaspases. Here, to isolate proteins that interact with caspase-7, we established a yeast two-hybrid screening system using reversed-caspase-7, a constitutive active mutant of caspase-7 as a bait plasmid. Screening of an adult brain cDNA library led to isolation of proteasome activator 28 subunit, PA28γ. In vitro translates of PA28γ were cleaved by both recombinant caspase-3 and -7. Mutagenesis of potential cleavage site DGLD80 to EGLE80 completely abolished caspase-mediated cleavage. Moreover, endogenous PA28γ was cleaved during not only Fas-induced apoptosis of HeLa cells, but also cisplatin-induced cell death of MCF7 cells, which are devoid of caspase-3. These findings indicate that PA28γ is an endogenous substrate for caspase-3 and -7 and that yeast two-hybrid screening using reversed-caspase is a novel and useful approach to clone substrates for effector caspases.
Similar content being viewed by others
Introduction
Apoptosis is an actively performed cellular suicidal process essential for the development and maintenance of tissue homeostasis of multi-cellular organisms. Apoptosis is characterized by prominent morphological features such as membrane blebbing, nuclear condensation, DNA fragmentation and apoptotic body formation. A family of cysteine proteases called caspases plays a critical role in the execution of apoptosis, from nematodes to humans. To date, 14 mammalian caspases have been identified.1 Caspases are synthesized as inactive zymogens that become activated by cleavage after a specific aspartate residue within a linker domain between a large subunit (LS) and a small subunit (SS), in addition to cleaving off of the NH2-terminal prodomain. The LS and SS subsequently combine into a heterodimer to form active caspases.2 When cells receive death signals, a subset of caspases are activated in an organized fashion and lead to processing and activation of crucial effector/executioner caspases.
Effector caspases, represented by caspase-3, -6 and -7, specifically cleave cellular proteins or ‘death substrates’, and govern the changes characterizing apoptotic morphology. Thus, death substrates play an important role in determining the final apoptotic phenotype. Caspase-dependent cleavage inactivates a subgroup of substrates such as PARP, nuclear lamin, Bcl-2 and β-catenin, whereas activates a different subgroup of substrates including MEKK1, p21-activated kinase, protein kinase Cδ and the ICAD/CAD complex.3 Although the role of death substrate cleavage in the apoptotic phenotype is partially understood, the substrates essential for causing cell death remain unknown.
Caspases-3 and -7 are closely related caspases in sequence similarity as well as in substrate specificity.4,5 Recombinant large or small subunit of caspase-7 can form active heteromeric complexes with the caspase-3 counterpart.4 Both caspases show overlapping substrate specificities with special preference for the DEVD motif. However, these highly related caspases are differentially regulated in subcellular localization during apoptosis, suggesting the presence of caspase-3 or -7 specific substrates.6 The role of caspase-7 is still ill-defined, unlike caspase-3 which has been shown to play a central role in apoptosis execution. Thus, we attempted to clone new substrates for caspase-7.
Recently, Srinivasula et al succeeded in generating a constitutive active recombinant caspase-3 and -6 by rearrangement of their subunits.7 These arranged forms of caspases were designated ‘reversed-caspases’ (rev-caspases), because the order of large and small subunits of these caspases are switched and reversed. Based on this technology, we devised rev-caspase-7, which is also constitutively active. Using an active-site mutant of rev-caspase-7 as bait, we performed yeast two-hybrid screening, resulting in the cloning of 20S proteasome activator 28 subunit 3, PA28γ. Subsequent studies showed that PA28γ is cleaved by caspase-3 or -7 both in vitro and in vivo, indicating that PA28γ is a new member of endogenous substrates for these effector caspases.
Results
Production of rev-caspase-7
Caspases are synthesized as inactive single-polypeptide zymogens and must be cleaved between the NH2-terminal of the large subunit (LS) and the COOH-terminal of the small subunit (SS) to be activated. Effector caspases, namely caspase-3, -6 and -7, cannot undergo autocatalytic processing and have an absolute requirement for ‘initiator’ caspases such as caspase-8 and -9 for processing.2
Srinivasula et al, based on the three-dimensional structure of active caspase-3, engineered contiguous caspase-3 and -6 molecules in which the SS was fused in-frame N-terminal to the LS, and a cleavage site (i.e., DEVDG in the case of caspase-3) was introduced between the two subunits7 (Figure 1A). In contrast to their wild-type counterparts, these engineered rev-caspases, in which SS precedes LS, were able to undergo antocatalysis in an in vitro translation reaction and potently induced apoptosis when over expressed in cells, indicating that rev-caspase-3 and -6 spontaneously fold into active conformation.
Because caspase-3 and caspase-7 are highly related molecules, we constructed rev-caspase-7 along with caspase-3 using essentially the same strategy as Srinivasula and his coworkers (Figure 1A). First, we examined whether wild-type procaspases and rev-caspases undergo autocatalytic processing in an in vitro translation reaction (Figure 1B). As expected, rev-caspase-3 and -7 (Rev) were able to undergo processing into LS and SS in an in vitro system, whereas wild-type caspase-3 and -7 (WT) were not.
Moreover, the processing was completely inhibited by mutating the active site cysteine to serine of rev-caspase-3 and -7 (Rev-C/S), indicating that rev-caspase-3 and -7 are catalyzed by their own activities (Figure 1B, lanes 3 and 6).
Rev-caspase-7 retains activity in yeast
Given that rev-caspase-7-folded into active conformation in an in vitro translation system, we decided to clone molecules that interact with caspase-7, including substrates and inhibitors, using a yeast two-hybrid screening with rev-caspase-7 as the bait. To determine whether rev-caspase-7 was also autoprocessed in yeast, we introduced cDNAs for wild-type procaspase-7, rev-caspase-7 and active site cysteine to serine mutant of rev-caspase-7 into the yeast two-hybrid vector pGilda. In this vector, cDNAs are expressed as NH2-terminal fusion proteins with the LexA DNA binding domain under control of the inducible GAL1 promoter. The expression of caspase-7 constructs was induced by incubation with galactose for 12 h and checked by Western blotting (Figure 2). Similar to the in vitro translation experiments, rev-caspase-7 (Rev) was auto-processed to produce the large subunit (LS), whereas the active site mutant of rev-caspase-7 (Rev-C/S) was not. Interestingly, unlike the in vitro translation product, procaspase-7 (WT) was partially cleaved. This processing is most likely caused by autocatalysis induced by artificial massive expression of recombinant procaspase-7 in yeast. Moreover, expression of rev-caspase-7 in yeast, but not that of procaspase-7 or active site mutant of rev-caspase-7, impaired cell growth, consistent with the previous finding that caspase-3 expression induces growth inhibition in an activity-dependent manner8 (data not shown).
Rev-caspase-7 and rev-caspase-7-C/S bind to natural caspase inhibitors in yeast
Baculovirus protein p35 and human inhibitor of apoptosis proteins (IAPs), XIAP, c-IAP1, c-IAP2 and survivin have been shown to tightly bind to and inhibit active caspase-7 but not inactive procaspase-7.9,10,11,12 Thus, we examined whether rev-caspase-7 also bound to these natural caspase inhibitors in yeast to obtain evidence that rev-caspase-7 behaves similarly to active caspase-7. Yeasts were co-transformed with galactose-inducible pGilda-wild-type procaspase-7, -rev-caspase-7 or -rev-caspase-7-C/S and a galactose-inducible pJG4-5 vector encoding cDNAs for XIAP, c-IAP1, c-IAP2 or survivin. As shown in Figure 3, rev-caspase-7 bound to XIAP, but not to c-IAP1, c-IAP2, or p35, whereas wild-type procaspase-7 did not bind to XIAP, as expected. The growth of yeasts expressing rev-caspase-7 was generally inhibited, except for the one strain that expressed both rev-caspase-7 and XIAP (data not shown). On the other hand, rev-caspase-7-C/S bound to p35, in addition to XIAP. The growth of yeasts expressing rev-caspase-7-C/S was not impaired. These results indicate that rev-caspase-7 binds to at least some caspase inhibitors in yeasts. Neither rev-caspase-7 nor rev-caspase-7-C/S mutant bound to c-IAP1, c-IAP2 or survivin, most likely because the binding affinities of these IAPs for caspase-7 are much lower than those of XIAP.11,13 Moreover, the inhibitory activity of p35 may not be strong enough to completely inhibit the activity of rev-caspase-7 in yeast, thus leading to growth arrest and a negative binding result. Based on these findings, we decided to use rev-caspase-7-C/S as bait in the screening of a yeast two-hybrid cDNA library in order to clone active caspase-7 interacting proteins, including substrates and inhibitors such as IAP or p35 related molecules.
Substrate candidates for caspase-7 were identified by yeast two-hybrid screening
We used pGilda-rev-caspase-7-C/S as a bait plasmid to screen a mouse adult brain cDNA library. A total of 110 positive clones were obtained by screening 2×106 transformants. Partial sequencing of positive clones yielded 20 candidate molecules for caspase-7 interacting protein. To examine whether these clones were substrates for caspase-7, in vitro translates of these clones were produced and incubated with recombinant caspases. As shown in Figure 4A, four of the 20 candidates were cleaved by recombinant caspases, suggesting that these proteins were caspase substrates. Clone #15 was cleaved only by caspase-7, whereas clones #52, #77, and #105 were cleaved by both caspase-3 and -7 and also by caspase-6 to a lesser extent. Moreover, these four clones were cleaved by recombinant caspases in a dose dependent manner (data not shown). These results indicate that this system is highly effective in identifying caspase substrates.
PA28γ was cleaved by caspase-3 and -7 in vitro
Of the substrate candidates, we focused on clone #105, which encoded mouse proteasome activator 28 subunit 3 (PA28γ), as evolutionarily it is a very well conserved protein from drosophila to humans and appears to have a biologically important role.14
First, we cloned full length human PA28γ cDNA and confirmed that human PA28γ was cleaved by recombinant caspase-3, -7 and also by caspase-6 to a lesser extent in vitro, consistent with partial clone (#105) cleavage (Figure 4B and data not shown). These results suggest that the cleavage site for caspases is conserved between human and mouse. In the human PA28γ sequence, we found a DGLD80G sequence, which was conserved in the corresponding sequence of mouse PA28γ and very well fitted the optimal tetrapeptide recognition sequence for caspase-3 or -7 (DEXD).15 To examine whether this sequence was the cleavage site, we constructed two PA28γ mutants: one with Asp-80 to Glu (DGLE80), named PA-DE, and the other with Asp-77 and -80 to Glu (EGLE80), named PA-EE. These mutants, PA-DE and PA-EE, were not cleaved by recombinant caspases, indicating that the caspase-3/-7 and caspase-6 cleavage site of human PA28γ was Asp-80 (Figure 4B and data not shown).
PA28γ was cleaved by caspase-7 in vivo
To examine the cleavage of PA28γ by caspase-7 in vivo, HEK 293T cells were co-transfected with HA-tagged caspase-7ΔN and caspase-7ΔN-C/S, of which the NH2-terminal 23 amino acids are deleted, and NH2-terminal Flag-tagged PA28γ. Unlike full-length procaspase-7, caspase-7ΔN was processed and induced cell death when over-expressed in mammalian cells (data not shown). As shown in Figure 5, PA-WT was cleaved by caspase-7ΔN, generating an 11 kDa N-terminal fragment, but not by caspase-7ΔN-C/S. The PA-EE mutant was not cleaved at all by caspase-7ΔN or caspase-7ΔN-C/S. Moreover, Flag-tagged PA28γ was co-immunoprecipitated with the rev-caspase-7-C/S mutant after both plasmids were co-transfected into HEK293T cells, and the PA-EE mutant, unlike the wild type, hardly bound to rev-caspase-7-C/S (data not shown). These data indicate that PA28γ interacts with and is cleaved by caspase-7 at Asp-80 in vivo, in exactly the same way as in an in vitro cleavage experiment.
PA28γ is an endogenous substrate of caspase-3/-7 like caspases
Next, we generated anti-serum against the C-terminal portion of PA28γ (81–92 a.a.), and checked the cleavage of endogenous PA28γ during Fas-induced apoptosis of HeLa K cells. As shown in Figure 6, PA28γ was cleaved with a similar time course to that of the cleavage of caspase-7 or -3 during apoptosis. Moreover, the cleavage was blocked by zVAD-fmk, an irreversible pan-caspase peptide inhibitor, and zDEVD-fmk, an irreversible peptide inhibitor for caspase-3/-7 like caspases. Although the cleavage of caspase-3 was not inhibited by zDEVD-fmk treatment, caspase-3 activity was blocked, and therefore PARP, the substrates of caspase-3 and -7, was not cleaved at all. Like PARP, PA28γ was not cleaved by caspase-3 and -7 upon zDEVD-fmk treatment. These findings indicate that PA28γ is directly cleaved by caspase-7, -3, or closely related caspases in vivo.
Finally we examined whether endogenous PA28γ is cleaved during the apoptosis of MCF-7 cells, which are devoid of caspase-3 owing to a functional deletion of the caspase-3 gene.16 Despite the lack of caspase-3, this cell line shows sensitivity to various death stimuli, providing an excellent system with which to test whether caspase-3 is indispensable for the cleavage of a specific death substrate.17 We induced apoptosis in MCF7 cells with addition of cisplatin and checked whether PA28γ was cleaved in apoptotic MCF7 cells. Very similar to anti-Fas antibody-treated HeLa K cells, PA28γ was cleaved with the concomitant processing of caspase-7, and the cleavage was inhibited by zVAD-fmk and zDEVD-fmk. These results indicate that endogenous PA28γ in MCF7 cells is cleaved by a DEVD-specific caspase other than caspase-3, most likely caspase-7 Figure 7.
Discussion
The yeast two-hybrid system is a versatile method with which to systematically identify interacting proteins. In the present study, we used this system to clone caspase substrates using genetically engineered rev-caspase-7, and successfully identified PA28γ as a substrate for caspase-3 or -7.
Previous to our study, Kamada et al developed a method of cloning the genes of caspase substrates using a modified yeast two-hybrid system, and identified gelsolin as a substrate of caspase-3.18 They expressed large and small subunits separately using ADH1 promoter, which ensured an equimolar ratio of these two subunits. Compared to their method, our method of adopting an active site mutant of rev-caspase as bait enables utilization of any commercially available yeast two-hybrid vector and appears to be more convenient. On the other hand, unlike the Kamada et al method, in our procedure an active site mutant of rev-caspase-7 (rev-caspase-7-C/S) remains a single polypeptide due to the lack of autocatalysis, raising the possibility that this mutant does not have the proper structure of active caspase. We addressed this concern by demonstrating specific binding between rev-caspase-7-C/S and natural caspase inhibitors including p35 and XIAP. Recent structural studies have demonstrated that both inhibitors bind to the active site of caspase-7, indicating that rev-caspase-7-C/S retains a substrate binding groove identical to that of active caspase-7.19,20,21,22 Since rev-caspase-3 and -6 have been engineered and shown to have the active form conformation, substrates for these caspases could also be systematically cloned using yeast two-hybrid screening with rev-caspases-C/S.7
In the present study, we have identified PA28γ as a substrate for caspase-3 or -7. PA28γ was originally termed Ki antigen, which was initially identified using autoantibodies found in sera of patients with systemic lupus erythematosus.23 Subsequent studies revealed that Ki antigen has sequence similarity to proteasome activators PA28α and PA28β, and was renamed PA28γ.24 PA28α and PA28β assemble into a heteromultimer called PA28, which has been shown to associate with and greatly stimulate multiple peptidase activities of the 20 S proteasome. PA28 is upregulated by stimulation with IFN-γ and thought to be involved in the generation of MHC class I ligands.25 In contrast, the physiological role of PA28γ is unclear. Mice deficient in the PA28γ gene are born without detectable developmental abnormalities.26 However, mild growth retardation of PA28γ−/− compared with PA28γ+/− or PA28γ+/+ mice has been observed. Moreover, embryonic fibroblasts derived from PA28γ−/− mice displayed a slower growth rate than those from wild-type mice, indicating that PA28γ is involved in cell proliferation. Since PA28γ localizes almost exclusively in the nucleus, it is speculated to play a role in the degradation of nuclear proteins regulating cell cycle progression.26,27 To examine the functional significance of the cleavage of PA28γ during apoptosis, we observed the effect of over-expression of PA28γEE, a caspase-uncleavable mutant of PA28γ, on apoptosis (refer to Figure 4). However, over-expression of PA28γEE did not affect either the time course or cell morphology during apoptosis of HEK 293 cells and SH-SY5Y cells induced by various stimuli including Fas overexpression and tunicamycin treatment, respectively12,28 (data not shown). Further study is required to clarify the significance of caspase-3/-7-mediated cleavage of PA28γ.
In conclusion, we have succeeded in identifying a novel substrate for caspase-3 or -7 using a yeast two-hybrid screening with rev-caspase-7 as bait. Systematic cloning of more caspase substrates using this convenient method will further elucidate the roles of caspases and their substrates in apoptosis.
Material and Methods
Reagents, cell culture and transfection
Benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (zVAD-fmk) and benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl ketone (zDEVD-fmk) were purchased from Peptide Institute (Osaka, Japan) and Enzyme Systems Products (Livermore, CA, USA).
HEK293T, HeLa K cells were kind gifts of Dr. S Yonehara and maintained in Dublecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum at 37°C in humidified 5% CO2/95% air. HEK293T cells were transfected using Lipofectamine PLUSTM reagent (Gibco BRL, Grand Island, NY, USA) according to the manufacturer's instructions. MCF-7 cells were obtained from ATCC (Rockville, MD, USA) and maintained in DMEM supplement with 10% fetal bovine serum at 37°C in humidified 5% CO2/95% air.
Construction of rev-caspase mutants
cDNAs encoding rev-caspase precursors were generated by PCR. Rev-caspase-3 was constructed as previously described.7
To construct rev-caspase-7, the large and small subunits of caspase-7 were amplified with the following primers using the caspase-7 cDNA as a template: LS-forward, CCGGATCCATGGCAGATGATCAGGGCTGTATT; LS-reverse, CTGCTCGAGTTAGTCGGCCTGGATGCCATCATC; SS-forward, GGAATTCTCGGGGCCCATCAATGACACA; SS-reverse, CCGGATCCATCAACTTCATCTTGACTGAAGTAGAGTTC. The LS PCR product was excised with BamHI/XhoI, while SS was excised with EcoRI/BamHI. These products were then simultaneously subcloned into the EcoRI/XhoI site of the mammalian expression vector pcDNA3 or that of the yeast expression vector pGilda.
Yeast transformation and characterization
The yeast strain EGY48 ((lexA operators)6-LEU2) was maintained on an appropriate dropout medium to select for plasmid marker expression. Transformations were performed using the LiOAc method using 1 μg of each plasmid (pGilda, pJG4-5, pSH18-34).
For cDNA library screening, EGY48 cells containing pGilda and pSH18-34 were grown in glucose containing synthetic dropout liquid medium lacking histidine and uracil (SD- His, Ura). The cells were then transformed with 125 μg of mouse adult brain cDNA library using the LiOAc method. Transformants were plated onto galactose/raffinose, X-gal-containing SD-Trp, His, Ura plates which lacks tryptophan in addition to histidine and uracil. An aliquot of transformants was also plated onto glucose-containing SD-Trp, His, Ura plates to determine transformation efficiency. The blue colonies on galactose/raffinose, X-gal-containing SD-Trp, His, Ura plates were spotted onto galactose/raffinose, X-gal -containing SD-Trp, His, Ura, Leu plates.
In vitro translation of caspases or positive yeast two-hybrid clones
Caspases and yeast two-hybrid clones were in vitro translated in the presence of [35S]methionine in rabbit reticulocyte lysate with a T7-RNA polymerase-coupled TNT kit (Promega, Madison, WI, USA), using the pcDNA3 constructs as templates according to the manufacturer's instructions.
Generation of anti-PA28γ polyclonal antibody
Antibodies were raised against a region of human PA28γ protein spanning amino acids 81–92, which are located immediately after the putative caspase-3/-7 cleavage site DGLD. A synthetic polypeptide (GPTYKKRRLDEC) was cross-linked to keyhole limpet hemocyanine (KLH, Pierce, Rockford, IL, USA), emulsified in Freund's adjuvant, and used to immunize rabbits (1 mg in complete Freund's adjuvant for the first injection, followed every 2–3 weeks by 1 mg in incomplete Freund's adjuvant). Rabbit serum were divided into aliquots and kept frozen at −20°C.
Immunoblot analyses
The yeast cell cultures were centrifuged at 5000×g and the cell pellet washed with sterile water and resuspended in lysis buffer (20 mM PIPES pH 7.2, 100 mM NaCl, 1 mM EDTA, 10% Sucrose, 0.1% CHAPS, 10 mM DTT). Equal volumes of acid-washed 0.6 mm glass beads were added to each sample followed by vortexing for 10×30 s with 1 min intervals on ice. Equal amounts of each sample (50 μg protein) were subjected to 16% SDS–PAGE followed by transfer to a PVDF membrane. The membrane was probed with anti-caspase-7 monoclonal antibody (MBL, Nagoya, Japan).
The mammalian cells (5×105) were washed with PBS and resuspended in lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% Nonidet P-40, 1 mM EDTA) with a protease inhibitor cocktail tablet (Roche Diagnostics, Mannheim, Germany). Equal amounts of each sample (30 μg protein) were subjected to 16% SDS–PAGE followed by transfer to a PVDF membrane. The membrane was probed with anti-PA28γ polyclonal antibody, anti-Flag monoclonal antibody (Sigma, St. Louis, MO, USA), anti-caspase-7 monoclonal antibody (MBL), anti-caspase-3 polyclonal antibody (a gift from Dr. Hong-Gang Wang) and anti-PARP monoclonal antibody (Clontech, Palo Alto, CA, USA).
Abbreviations
- rev-caspase:
-
reversed caspase
- rev-caspase-7-C/S:
-
the active site mutant of reversed caspase-7
- PA28γ:
-
proteasome activator 28 subunit 3
- XIAP:
-
X-linked inhibitor of apoptosis protein
- zVAD-fmk:
-
benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone
- zDEVD-fmk:
-
benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl ketone
References
Hu S, Snipas SJ, Vincenz C, Salvesen G, Dixit VM . 1998 Caspase-14 is a novel developmentally regulated protease J. Biol. Chem. 273: 29648–29653
Salvesen GS, Dixit VM . 1997 Caspases: intracellular signaling by proteolysis Cell 91: 443–446
Thornberry NA, Lazebnik Y . 1998 Caspases: enemies within Science 281: 1312–1316
Fernandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L, Tomaselli KJ, Wang L, Yu Z, Croce CM, Salveson G, Earnshaw WC, Litwack G, Alnemri ES . 1995 Mch3, a novel human apoptotic cysteine protease highly related to CPP32 Cancer Res. 55: 6045–6052
Duan H, Chinnaiyan AM, Hudson PL, Wing JP, He WW, Dixit VM . 1996 ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis J. Biol. Chem. 271: 1621–1625
Chandler JM, Cohen GM, MacFarlane M . 1998 Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver J. Biol. Chem. 273: 10815–10818
Srinivasula SM, Ahmad M, MacFarlane M, Luo Z, Huang Z, Fernandes-Alnemri T, Alnemri ES . 1998 Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits J. Biol. Chem. 273: 10107–10111
Wright ME, Han DK, Carter L, Fields S, Schwartz SM, Hockenbery DM . 1999 Caspase-3 inhibits growth in Saccharomyces cerevisiae without causing cell death FEBS Lett. 446: 9–14
Zhou Q, Salvesen GS . 2000 Viral caspase inhibitors CrmA and p35 Methods Enzymol. 322: 143–154
Deveraux QL, Takahashi R, Salvesen GS, Reed JC . 1997 X-linked IAP is a direct inhibitor of cell-death proteases Nature. 388: 300–304
Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC . 1997 The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases EMBO J. 16: 6914–6925
Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, Reed JC . 1998 A single BIR domain of XIAP sufficient for inhibiting caspases J. Biol. Chem. 273: 7787–7790
Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC . 1998 IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs Cancer Res. 58: 5315–5320
Masson P, Andersson O, Petersen UM, Young P . 2001 Identification and Characterization of a Drosophila Nuclear Proteasome Regulator. A HOMOLOG OF HUMAN 11 S REGgamma (PA28gamma) J. Biol. Chem. 276: 1383–1390
Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, Chapman KT, Nicholson DW . 1997 A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis J. Biol. Chem. 272: 17907–17911
Janicke RU, Sprengart ML, Wati MR, Porter AG . 1998 Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis J. Biol. Chem. 273: 9357–9360
Janicke RU, Ng P, Sprengart ML, Porter AG . 1998 Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis J. Biol. Chem. 273: 15540–15545
Kamada S, Kusano H, Fujita H, Ohtsu M, Koya RC, Kuzumaki N, Tsujimoto Y . 1998 A cloning method for caspase substrates that uses the yeast two-hybrid system: cloning of the antiapoptotic gene gelsolin Proc. Natl. Acad. Sci. USA 95: 8532–8537
Xu G, Cirilli M, Huang Y, Rich RL, Myszka DG, Wu H . 2001 Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex Nature 410: 494–497
Huang Y, Park YC, Rich RL, Segal D, Myszka DG, Wu H . 2001 Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain Cell 104: 781–790
Chai J, Shiozaki E, Srinivasula SM, Wu Q, Dataa P, Alnemri ES, Shi Y . 2001 Structural basis of caspase-7 inhibition by XIAP Cell 104: 769–780
Suzuki Y, Nakabayashi Y, Nakata K, Reed JC, Takahashi R . 2001 XIAP inhibits caspase-3 and -7 in distinct modes J. Biol. Chem. 18: 18
Tojo T, Kaburaki J, Hayakawa M, Okamoto T, Tomii M, Homma M . 1981 Precipitating antibody to a soluble nuclear antigen ‘Ki’ with specificity for systemic lupus erythematosus Ryumachi. 21: 129–140
Ahn JY, Tanahashi N, Akiyama K, Hisamatsu H, Noda C, Tanaka K, Chung CH, Shibmara N, Willy PJ, Mott JD . 1995 Primary structures of two homologous subunits of PA28, a gamma-interferon-inducible protein activator of the 20S proteasome FEBS Lett. 366: 37–42
Tanaka K, Kasahara M . 1998 The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28 Immunol. Rev. 163: 161–176
Murata S, Kawahara H, Tohma S, Yamamoto K, Kasahara M, Nabeshima Y, Tanaka K, Chiba T . 1999 Growth retardation in mice lacking the proteasome activator PA28gamma J. Biol. Chem. 274: 38211–38215
Wojcik C, Tanaka K, Paweletz N, Naab U, Wilk S . 1998 Proteasome activator (PA28) subunits, alpha, beta and gamma (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells Eur. J. Cell. Biol. 77: 151–160
Imai Y, Soda M, Takahashi R . 2000 Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity J. Biol. Chem. 275: 35661–35664
Acknowledgements
We thank Dr. John Reed, Dr. Guy Salvesen and Dr. Paul Friesen for cDNAs for IAPs, caspases and p35, respectively. We also thank Dr. Yasuyuki Suzuki and Dr. Yuzuru Imai for valuable advice and discussion. This work was funded by research grants from RIKEN BSI, a Grant-in-Aid from the Japan Society for the Promotion of Science and grants from the Ministry of Health and Welfare, Japan.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by H Ichijo
Rights and permissions
About this article
Cite this article
Araya, R., Takahashi, R. & Nomura, Y. Yeast two-hybrid screening using constitutive-active caspase-7 as bait in the identification of PA28γ as an effector caspase substrate. Cell Death Differ 9, 322–328 (2002). https://doi.org/10.1038/sj.cdd.4400949
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400949
Keywords
This article is cited by
-
Evidence for anti-apoptotic roles of proteasome activator 28γ via inhibiting caspase activity
Apoptosis (2015)
-
Many cuts to ruin: a comprehensive update of caspase substrates
Cell Death & Differentiation (2003)